ZA872161B - Particles suitable for tabletting into diagnostic reagents - Google Patents

Particles suitable for tabletting into diagnostic reagents

Info

Publication number
ZA872161B
ZA872161B ZA872161A ZA872161A ZA872161B ZA 872161 B ZA872161 B ZA 872161B ZA 872161 A ZA872161 A ZA 872161A ZA 872161 A ZA872161 A ZA 872161A ZA 872161 B ZA872161 B ZA 872161B
Authority
ZA
South Africa
Prior art keywords
tabletting
diagnostic reagents
particles suitable
particles
reagents
Prior art date
Application number
ZA872161A
Other languages
English (en)
Inventor
K. Mcgeehan John
Original Assignee
Merck Patent Gesellschaft Mit Beschraenkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gesellschaft Mit Beschraenkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschraenkter Haftung
Publication of ZA872161B publication Critical patent/ZA872161B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA872161A 1986-03-24 1987-03-24 Particles suitable for tabletting into diagnostic reagents ZA872161B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/842,968 US4820627A (en) 1986-03-24 1986-03-24 Method of preparing particles suitable for tabletting into diagnostic reagents

Publications (1)

Publication Number Publication Date
ZA872161B true ZA872161B (en) 1987-09-17

Family

ID=25288715

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872161A ZA872161B (en) 1986-03-24 1987-03-24 Particles suitable for tabletting into diagnostic reagents

Country Status (8)

Country Link
US (1) US4820627A (xx)
EP (1) EP0238951B1 (xx)
JP (1) JPS62232567A (xx)
CA (1) CA1303490C (xx)
CS (1) CS274290B2 (xx)
DE (1) DE3778948D1 (xx)
IL (1) IL81963A (xx)
ZA (1) ZA872161B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4027728A1 (de) * 1990-08-31 1992-03-05 Bayer Ag Immobilisierung von organischen makromolekuelen oder biopolymeren in einer polymermembran
ATE158180T1 (de) * 1991-06-21 1997-10-15 Univ Cincinnati Oral verabreichbare therapeutische proteine und herstellungsverfahren
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
US5776563A (en) 1991-08-19 1998-07-07 Abaxis, Inc. Dried chemical compositions
US5413732A (en) * 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
ES2103969T3 (es) * 1991-10-11 1997-10-01 Abbott Lab Composicion de reactivo en dosis unitaria para dosificados por union especifica.
ES2095001T5 (es) * 1992-12-22 2001-03-16 Univ Cincinnati Una composicion terapeutica administrable oralmente y su metodo de obtencion.
US6068874A (en) * 1993-02-16 2000-05-30 Dehydration Technologies, Inc. Process of dehydrating biological products
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres
US6268012B1 (en) 1996-06-07 2001-07-31 Dtl S.A. Dried product and a drying process
DE19622885A1 (de) * 1996-06-07 1997-12-11 Boehringer Mannheim Gmbh Reagenzzubereitung enthaltend magnetische Partikel in Form einer Tablette
US20040022666A1 (en) * 1998-06-30 2004-02-05 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
US20060003447A1 (en) * 2003-12-30 2006-01-05 Richard Fike Dry powder cells and cell culture reagents and methods of production thereof
US6383810B2 (en) 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US6627426B2 (en) 1997-02-14 2003-09-30 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
DE19922753A1 (de) * 1999-05-18 2000-11-23 Basf Ag Enzym-Instantformulierungen für die Tierernährung
JP4536304B2 (ja) * 1999-07-14 2010-09-01 スペクトラル ダイアグノスティックス インコーポレイテッド 診断試験用球体の調製
EP1339829B1 (en) * 2000-11-06 2018-10-24 Life Technologies Corporation Dry powder cell culture media and methods of production thereof
CA2468742A1 (en) * 2001-11-30 2003-06-12 Invitrogen Corporation Cell culture media
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
PT1500390E (pt) * 2003-07-25 2005-10-31 Ferring Bv Composicao farmaceutica como forma de dosagem solida e metodo de producao
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
WO2005061088A1 (en) * 2003-12-22 2005-07-07 Finlay Warren H Powder formation by atmospheric spray-freeze drying
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
US20070259348A1 (en) * 2005-05-03 2007-11-08 Handylab, Inc. Lyophilized pellets
EP1870649A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
ES2352299T3 (es) * 2007-02-14 2011-02-17 Laboratorios Lesvi, S.L. Composiciones farmacéuticas que contienen fumarato de quetiapina.
US8835157B2 (en) * 2007-04-25 2014-09-16 3M Innovative Properties Company Supported reagents, methods, and devices
US20110020947A1 (en) * 2007-04-25 2011-01-27 3M Innovative Properties Company Chemical component and processing device assembly
US20100209927A1 (en) * 2007-11-06 2010-08-19 Menon Vinod P Processing device tablet
EP2143496A1 (en) * 2008-07-09 2010-01-13 F. Hoffmann-Roche AG Lysis reagent formulation containing magnetic particles in tablet form
TW201402153A (zh) * 2012-04-04 2014-01-16 Lonza Ag 菸鹼醯胺粉末和其製備方法及裝置
MX359554B (es) * 2012-04-25 2018-10-02 Spi Pharma Inc Microesferas cristalinas y proceso para fabricacion de las mismas.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA888690A (en) * 1966-04-25 1971-12-21 B. Mccarty Charles Enzyme-containing detergent compositions
US3413198A (en) * 1966-06-30 1968-11-26 Calbiochem Reagents and method for assaying biological samples
US3539450A (en) * 1966-06-30 1970-11-10 Calbiochem Stabilization of enzymes
US3527331A (en) * 1966-06-30 1970-09-08 Calbiochem Reagent for assaying aldolase
GB1237144A (en) * 1968-07-26 1971-06-30 Pfizer Ltd Coating method
US3687853A (en) * 1969-06-06 1972-08-29 Colgate Palmolive Co Granulation process
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
GB1530238A (en) * 1976-05-04 1978-10-25 Du Pont Method of determining lipase activity using a triglyceride reagent and method for preparing that reagent
GB1590432A (en) * 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
EP0021572A1 (en) * 1979-06-04 1981-01-07 American Hospital Supply Corporation A substrate for use in a turbidimetric assay for lipase and a method for making this substrate
US4447527A (en) * 1980-09-02 1984-05-08 Syva Company Single test formulations for enzyme immunoassays and method for preparation
US4428973A (en) * 1980-11-17 1984-01-31 Saat- Und Erntetechnik Gmbh Method for the homogeneous complete encapsulation of individual grains of pourable material and apparatus for its production
JPS5841836A (ja) * 1981-09-08 1983-03-11 Teijin Ltd 光学活性４−ヒドロキシシクロペンテノン誘導体及びその製造法
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
DK149079C (da) * 1982-10-06 1986-06-23 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzympraeparat
US4578876A (en) * 1983-04-08 1986-04-01 Babcock Spraymixer Limited Process and apparatus for spraying a powder with liquid
US4689297A (en) * 1985-03-05 1987-08-25 Miles Laboratories, Inc. Dust free particulate enzyme formulation

Also Published As

Publication number Publication date
EP0238951A2 (en) 1987-09-30
JPS62232567A (ja) 1987-10-13
IL81963A0 (en) 1987-10-20
EP0238951B1 (en) 1992-05-13
CS191787A2 (en) 1990-09-12
DE3778948D1 (de) 1992-06-17
IL81963A (en) 1990-12-23
CA1303490C (en) 1992-06-16
US4820627A (en) 1989-04-11
EP0238951A3 (en) 1988-01-07
CS274290B2 (en) 1991-04-11

Similar Documents

Publication Publication Date Title
EP0238951A3 (en) Particles suitable for tabletting into diagnostic reagents
GB8700879D0 (en) Biological indicator
EP0272043A3 (en) Diagnostic device
GB8602732D0 (en) Taking samples from patients
GB8600582D0 (en) Purifying biological materials
NZ219609A (en) Assay methods for inhibin
GB8624064D0 (en) Chemical analysis
GB8624587D0 (en) Particle analysis apparatus
ZA907858B (en) Differential diagnostic assay for brucellosis
GB2190189B (en) Assay for polynucleotides
EP0252567A3 (en) Biochemical process
GB8715282D0 (en) Analysis
GB8701195D0 (en) Chemical analysis system
GB2202637B (en) Analysis
GB8431170D0 (en) Diagnostic reagents
EP0295893A3 (en) Ultrasonic analyzers
GB8625957D0 (en) Image analysis system
GB8627732D0 (en) Fluid collection assemblies
GB8629786D0 (en) Diagnostic techniques
GB8615729D0 (en) Detecting interfaces
GB8818531D0 (en) Diagnostic reagent
CS477886A1 (en) Laboratory fermentor
GB8505400D0 (en) Diagnostic reagents
GB8513924D0 (en) Diagnostic reagents
GB8616612D0 (en) Biochemical process